(Q46531267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

N G Mikhaeel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

P A Fields

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

T Nunan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

A R Timothy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

6 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1160-1168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

FDG-PET in the clinical management of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Current therapies in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI200

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15939713%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference